Skip to contentpdufa.bio

Karisma Follow-up

Page updated ·next FDA decision on the calendar ·Data as of Nov 19, 2026 12:24 AM ET

Karisma Follow-up is an Atossa Therapeutics, Inc. program. Its next catalyst is a Readout in Dec 2026.

ATOS catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Atossa Therapeutics, Inc. (ATOS). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Dec 2026ATOS

Questions

When is Karisma Follow-up's next FDA decision or readout?

The next tracked catalyst for Karisma Follow-up is a Readout in Dec 2026.

What happened at Karisma Follow-up's most recent FDA decision?

No FDA decision for Karisma Follow-up is in our archive yet.

Who makes Karisma Follow-up?

Atossa Therapeutics, Inc. (ATOS).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings. Each FDA decision links its own page, which names its source or says plainly that it has none.